Trustees’ Annual Report, 2021-22 In 2021-22, the charity primarily focused on deployment of resources to fund medical relief in Sri Lanka. Our most significant project this year was the fulfilment of our partnership with American charity Medical Bridges, with whom we donated and delivered over $220,000 of medical equipment to Sri Lanka’s Colombo National Hospital. Plans were also put in place for several other projects including the preparation of an itinerary for a team of cleft lip specialists to visit Sri Lanka to aid with local training, the donation of one or more ambulances to the country’s 1990 ambulance service, and the donation of trauma-training-specific equipment to the Jaffna teaching hospital. We thank our patrons for their continued support and are pound to continue our work in Sri Lanka. The charity continues to look for new projects to commit to in the memory of Amelie and Daniel Linsey. Prepared by: David Linsey _Trustee, The Amelie and Daniel Linsey Foundation_ |**Charity Name**|**No (if any)**||| |---|---|---|---| |**The Amelie and Daniel Linsey Foundation**|**1189206**||| |**Receipts and payments accounts**|||**CC16a**| |02/12/2021
Period start
**To**
**For the period**
**from**|01/12/2022
Period end date||| |**Section A Receipts and payments**|**Section A Receipts and payments**|**Section A Receipts and payments**|**Section A Receipts and payments**|**Section A Receipts and payments**|||||| |---|---|---|---|---|---|---|---|---|---| |**A1 Receipts**|**Unrestricted funds**
**to the nearest £**
**20,659**
**84**
**-**
**-**
**-**
**-**
**-**
**-**
**20,743**

**-**
**-**
**-**
**20,743**||**Restricted funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**Endowment funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**Total funds**
**to the nearest £**
**20,659**
**84**
**-**
**-**
**-**
**-**
**-**
**-**
**20,743**
**-**
**-**
**-**
**20,743**||**Last year**
**to the nearest £**| |Donations|**20,659**||||||||**205,000**| |Interest|**84**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**-**||||||||**-**| |**_Sub total_**_(Gross_
_income for AR)_|**20,743**||||||||**205,000**| ||||||||||| |**A2 Asset and investment sales,**
**(see table).**|||||||||| ||**-**||||||||| ||**-**||||||||**-**| |**_Sub total_**|**-**||||||||**-**| |**_Total receipts_**
**A3 Payments**|||||||||| ||||||||||**205,000**| ||||||||||| |
Medical Equipment Costs|**25,250**||**-**||**-**||**25,250**||**-**| |OperatingExpenses|**284**||**-**||**-**||**284**||**-**| ||**-**||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**||**-**| |**_Sub total_ **|**25,534**||**-**||**-**||**25,534**||**-**| ||||||||||| |**A4 Asset and**
**investment**|||||||||| ||**-**||||||||| ||**-**||||||||| |**_Sub total_ **|**-**||||||||**-**| |**_Total payments_ **
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||||| ||||||||||**-**| ||||||||||| ||**- 4,791**||||||||**205,000**| ||**-**||||||||**-**| ||**-**||||||||**-**| ||**- 4,791**||||||||**205,000**| CCXX R1 accounts (SS) 11/10/2023 1 ## **Section B Statement of assets and liabilities at the end of the period** |
**Categories**
Signed by one or two
trustees on behalf of all
the trustees
**B1 Cash funds**
**B2 Other monetary**
**assets**
**B4 Assets retained**
**for the charity’s**
**own use**
**B5 Liabilities**
**B3 Investment**
**assets**|Signature
**Details**
**Details**
Bank account
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))

**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**200,222**
**-**
**-**
**-**
**-**
**-**
**200,222**
**-**
Agreement
Error
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
David Linsey|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||David Linsey|1st October 2023| ||||| CCXX R2 accounts (SS) ~~11/10~~ /2023 ~~2~~